Bladder cancer discoveries implemented in multidisciplinary teams Aug. 09, 2022 Overview Show transcript Overview Timothy D. Lyon, M.D., Carlos E. Vargas, M.D., and Roxana S. Dronca, M.D., are bladder cancer experts at Mayo Clinic Comprehensive Cancer Center. They explain how their multidisciplinary team's expertise can optimize every part of bladder cancer treatment. Advancements in diagnostics, drug development, genomics and immunotherapy, as well as cutting-edge robotic assisted surgery and radiation therapy, open new doors for treating this disease. Many of these innovations have been discovered in clinical trial settings. A multidisciplinary approach to bladder cancer management allows patients access to the latest medical research at the forefront of new bladder cancer discoveries. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoBladder cancer treatment optionsArticleStudy assesses cost-effectiveness of pembrolizumab for treatment of bacillus Calmette-Guerin-unresponsive bladder carcinoma in situArticleLymph node dissection during radical cystectomy for patients with nonmuscle-invasive bladder cancer VID-20537210 Medical Professionals Bladder cancer discoveries implemented in multidisciplinary teams